T he effectiveness of nutritional support in modulating the chain of inflammatory response and in reducing demands of the respiratory system through use of nutritional intervention has received a growing attention as a result of its capacity to interfere in a variety of biological processes (1) . Nutritional formulations that are low in carbohydrates and rich in lipids may reduce minute ventilation and ventilatory demand, leading to a reduction of respiratory coefficient and CO 2 production (2). Gadek et al. ( 3) used a high-lipid enteral diet enriched with eicosapentaenoic acid (EPA or fish oil), ␥-linolenic acid (GLA or borage oil), and enhanced levels of antioxidant vitamins in patients with acute respiratory distress syndrome (ARDS), demonstrating a significant improvement, not only in the PaO 2 / FIO 2 ratio but also in several outcomes such as ventilator-free days, intensive care unit (ICU)-free days, and reduced new organ dysfunctions.
Recent pharmaceutical interventions proposed for sepsis have sought to focus on regulating the chain of pro-and antiinflammatory mediators (4, 5) responsible for causing the systemic characteristics of the disease and, consequently, for leading to multiple organ failure. The inflammatory reaction is capable of activating synthesis of lipid mediators, such as prostaglandin E2, which are involved in the complex regulation of the inflammatory process (6) .
Many of these inflammatory mediators are metabolites of omega-6 fatty acids, such as linoleic acid and the product of its elongation/desaturation, arachidonic acid (7) . Substitution of omega-6 fatty acids by fatty acids rich in omega-3, such as EPA, has proven to be beneficial in modulating the inflammatory processes both in animal models and in humans (8 -16) .
Interest has also grown around the potential metabolic effects of GLA. This oil is rapidly lengthened to dihomo-␥-linolenic acid (DGLA) and is incorporated into tissue lipids. DGLA may, among other effects, suppress biosynthesis of leukotrienes, being rapidly metabolized to monoenoic pros-taglandins (17) . In addition, although EPA allows the elongation of GLA into DGLA, it tends to prevent its desaturation into arachidonic acid. This mechanism can produce an increase in 1 series prostanoids and a decrease in 2 series eicosanoids.
Research using animal models of sepsis-induced ARDS has shown that a diet low in carbohydrates and rich in EPA and GLA may modulate the production of inflammatory mediators, improving the functional capacity of the lungs. This type of diet is capable of rapidly reducing the phospholipid fatty acid content of arachidonic acid in inflammatory cell membranes (18) , even if administered parenterally (19) . In animal models of sepsis, a diet enriched with omega-3 fatty acids has been associated with reduced mortality rate (20 -23) .
This study seeks to investigate the effects of an enteral diet enriched with EPA, GLA, and elevated levels of antioxidant vitamins in patients with severe sepsis or septic shock requiring mechanical ventilation.
MATERIALS AND METHODS

Study Design and Ethical
Aspects. This was a prospective, single-center, randomized, double-blinded, controlled trial comparing the effects of enteral nutrition enriched with EPA, GLA, and elevated levels of antioxidant vitamins with that of an isonitrogenous and isocaloric control diet in patients diagnosed with either severe sepsis or septic shock and requiring mechanical ventilation. Patients were recruited from three different adult ICUs (one medical, one cardiology, and one postsurgical ICU) of a single tertiary hospital during a 15-month period.
This study was approved by the Institutional Review Board before patient enrollment. Informed consent was obtained from all patients or their legal representatives. All patients were treated in accordance with the Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (24) . Patients received steroids when they remained hypotensive despite an adequate fluid replacement of 200 -300 mg/day of hydrocortisone for 7 days in four divided doses. Adequate initial resuscitation was given to all patients with sepsisinduced tissue hypoperfusion in accordance with the protocol of Rivers et al. (25) .
Study Patients. Patients were enrolled under the conditions of being Ͼ18 yrs of age, requiring mechanical ventilation (with a maximum PaO 2 /FIO 2 ratio Ͻ200, no minimum value was established), having enteral access, and having a clinical diagnosis of either severe sepsis or septic shock, according to the criteria defined by Bone et al. (26) and modified by Bernard et al. (27) . Cardiovascular, renal, hematologic, hepatic, and neurologic failures were defined by previously published criteria (27) . Gastrointestinal failure was assessed using the criteria previously defined by Gadek et al. (3) .
The main reasons for exclusion were pregnancy or breastfeeding, Ͻ18 yrs of age, significant limitation of survival prognosis (defined as a life expectancy Ͻ28 days due to a chronic and/or incurable disease such as uncontrolled cancer or other terminal disease), preexisting chronic renal insufficiency (acute renal insufficiency was not considered an exclusion criteria), acute pancreatitis without established origin, participation in another clinical trial Ͻ30 days before, head trauma with a Glasgow Coma Scale score Յ5, recent stroke or subarachnoid hemorrhage, important immunologic suppression (defined as a leukocyte count Ͻ5000 cells/mm 3 ), infection by the human immunodeficiency virus, no indication for enteral nutrition or imminence of receiving parenteral nutrition, receiving partial parenteral nutrition, presence of uncontrolled diarrhea, recent gastrointestinal bleeding event, planned weaning from mechanical ventilation before study day 4, and exclusion from the protocol by physicians' decision. Baseline demographic and clinical characteristics are shown in Table 1 .
Randomization and Study Diet Administration. Patients were randomized in a ratio of 1:1 in a blinded way. The control diet was a high-fat, low-carbohydrate enteral formulation, balanced for patients with pulmonary diseases. The experimental diet was enriched with EPA, GLA, and enhanced levels of antioxidant vitamins, although it remained isocaloric and isonitrogenous to the control diet. The full composition of the two diets can be found in Table 2 . Patients received enteral nutrition within 6 hrs of meeting entry criteria. Enteral feeding was delivered at a constant rate to achieve a minimum of 50% basal energy expenditure (BEE; determined using the Harris-Benedict equation) ϫ 1.3 within the first 24 hrs (28) . If well tolerated, enteral nutrition was advanced to achieve a minimum of 75% of BEE ϫ 1.3 within 72 hrs. The enteral diets were delivered until patients were extubated or until interrupted at physician's discretion or due to the development of any adverse event that could be related to the enteral feeding.
The day on which patients fulfilled all entry criteria was considered baseline, and the first day the patient received a minimum of 75% of BEE ϫ 1.3 was considered study day 1. Enteral diet was delivered continuously for a mini- mum of 4 study days at a rate not exceeding BEE ϫ 1.3. The daily enteral intake was recorded to obtain total volume and calories delivered to the patient. Laboratory Data, Outcome Measures, and Statistical Analysis. Blood samples were obtained for routine laboratory testing at least at baseline and on study days 4 and 7. The PaO 2 / FIO 2 ratio was assessed at least daily during the feeding period. A simultaneous recording of ventilator settings was also performed. Weaning from mechanical ventilation was performed using the protocol previously described by Esteban et al. (29) .
The primary issue was to determine the mortality rate from any cause during a 28-day follow-up period. Secondary issues included changes in oxygenation status, time receiving mechanical ventilation, period in the intensive care setting, and development of new organ dysfunctions.
Oxygenation status was determined by the PaO 2 /FIO 2 ratio. Time receiving mechanical ventilation and period in the intensive care unit were defined as the number of days from study entry (baseline) to the actual day that a patient remained on a ventilator or in the ICU, respectively, during the 28-day period. New organ dysfunction was defined as the development of any new organ failure (cardiovascular, renal, hematologic, hepatic, neurologic, and gastrointestinal) during the 28-day follow-up that had not been present at time of entry (baseline), or the development of a new respiratory failure requiring new ventilatory support. The criteria used to determine new organ failures were the same used to determine baseline dysfunctions.
A patient was considered evaluable if baseline measures of oxygenation were obtained, a feeding period of 4 days from study day 1 was realized, all clinical measures of oxygenation were available, and the patient was monitored until the end of the 28-day follow-up period or when death occurred. After reaching 30 assessable patients, we performed an interim analysis (30) using the O'Brien and Fleming method (31) .
At the time of the final statistical analysis, the database was sent to an independent statistical company (Statconsultoria, São Paulo, Brazil), and the data with a total of 103 patients were deemed assessable. The statistical analysis of all patients enrolled but not completing through study day 4 was also performed to obtain the reasons for nonfulfillment of the study criteria. Intent-to-treat analysis was not performed or planned prospectively. Differences were assessed using the chi-square test, or Fisher's exact test if appropriate for categorical variables, and the Student's t-test for continuous variables (32) .
Estimates of survival curves were calculated using the Kaplan-Meier product-limit method (33) and compared by using the logrank test (34) . The Newcombe-Wilson method without continuity correction was used to calculate a confidence interval for the difference between two proportions (35) . Confidence intervals for relative risk are calculated using the methods described by Armitage and Berry (36) .
One-way analysis of variance with repeated measures was used to provide comparisons among groups of the changes in the response variable from baseline at each of the successive measurements.
All p values were two-tailed. A p Ͻ .05 was considered statistically significant. All computations were performed using SAS version 8.2 software (SAS Institute, Cary, NC) and Minitab version 14.1 (Minitab, State College, PA). All data are expressed as mean Ϯ SE or as indicated. 
RESULTS
Study Groups. A total of 165 patients were enrolled, of whom 103 patients were deemed evaluable. Data from 62 patients were excluded from the final analysis before unblinding because of protocol violations. This number is within our expectations and in accordance with similar studies (3). The major reasons for exclusion are described in Table 3 . There were no significant differences with respect to the delay in intensive care admission or rates of preexisting diabetes, hyperglycemia, and hypertension. Sixty-eight of the 103 evaluable patients started the study within 7 days of hospital admittance; 85 patients began the study within 14 days of admittance; and 18 patients began after 2 wks of hospitalization. The percentage of patients within these categories was comparable between the two dietary groups. Corticoids were used in 13 patients in the control group (mean total dose 246.15 Ϯ 18.3 mg) and 17 patients in the study group (mean total dose 241.17 Ϯ 17.3 mg). There are no statistically significant differences between the groups in relation to the use of corticoids.
Fifty-five of the evaluable patients were randomized to receive the study diet and 48 the control diet. A total of 42 patients from study day 4 did not complete through study day 7 (21 in each group). Table 4 describes the main reasons for discontinuation before study day 7. The mean dietary intake was similar between groups for total calories (1621 Ϯ 48 vs. 1647 Ϯ 74 total kcal per 24 hrs, p Ͼ .2), lipids (101 Ϯ
g/day EPA, 2.2 Ϯ 0.06 g/day docosahexaenoic acid (DHA), and 4.6 Ϯ 0.13 g/day GLA. Control patients did not receive these fatty acids. The study group also received significantly higher amounts of vitamin C (907 Ϯ 27 vs. 348 Ϯ 16 mg per day, p ϭ .0001) and vitamin E (346 Ϯ 10 vs. 71 Ϯ 3 international units per 24 hrs, p ϭ .0001).
The average time from study entry to the beginning of the enteral diet was similar between the study and control groups (3.2 Ϯ 0.4 vs. 3.4 Ϯ 0.3 hrs, respectively, p Ͼ .05). Average time to achieve 75% of BEE ϫ 1.3 (study day 1) was also similar (25.7 Ϯ 4.2 vs. 26.4 Ϯ 3.4 hrs). A complete description of the observed adverse events is shown in Table 5 .
Mortality. At day 28, there were 18 deaths (33%) in the group that received EPAϩGLA compared with 25 deaths (52%) in the control group. The absolute risk reduction for mortality was 19.4% (95% confidence interval 0.3-36.7%), and the relative risk of death for the group that received the study diet was 0.63 (95% confidence interval 0.39 -1.00). Cumulative event curves for 28-day all-cause mortality were estimated using the Kaplan-Meier method and compared with the log-rank test (Fig.  1) . The enteral feeding with EPAϩGLA was associated with a higher survival (p ϭ .037). The number of patients needed to treat to save an additional life at day 28 was 5 (95% confidence interval 3-319).
Respiratory Gas Exchange. There were no statistically significant differences in PaO 2 , FIO 2 , and PaO 2 /FIO 2 between the groups at baseline. All patients included in this study had severely compromised oxygenation status, placing them in the ARDS category in accordance with the consensus definition of a PaO 2 /FIO 2 ratio of Ͻ200 (37). The PaO 2 /FIO 2 ratio remained unchanged for patients receiving the control diet until study day 7. In contrast, patients receiving the study diet had statistically significant increases in PaO 2 /FIO 2 ratios on study days 4 and 7, depicted in Figure 2 . All patients who were extubated between day 4 and day 7 were excluded from this analysis.
No differences were observed in baseline PaO 2 /FIO 2 ratio between the two groups (156.1 Ϯ 2.5 vs. 158.4 Ϯ 2.7, p Ͼ .05). However, patients fed with the study diet increased their PaO 2 when compared with the control group on study day 4 and maintained this improvement until study (24) EPA, eicosapentaenoic acid; GLA, ␥-linolenic acid. Values are n (%). day 7. The increase in PaO 2 was accompanied by a decrease in FIO 2 , positive endexpiratory pressure, and minute ventilation (Table 6 ). This did not occur with the control group.
ICU and Ventilator Outcomes
Patients fed study diet had more ventilator-free days when compared with patients fed control diet (13.4 Ϯ 1.2 vs.  5.8 Ϯ 1.0, respectively, p Ͻ .001) (Fig. 3) . In addition, patients fed EPAϩGLA had more ICU-free days than patients fed the control diet (10.8 Ϯ 1.1 vs. 4.6 Ϯ 0.9, respectively, p Ͻ .001) (Fig. 4) .
The development of new organ dysfunction was also analyzed. Patients fed with EPAϩGLA developed less new organ dysfunction compared with patients fed with the control diet (38 vs. 81%, respectively, p Ͻ .001). When a comparison evaluating each individual organ dysfunction was performed, patients fed with the study diet developed less cardiovascular, renal, hematologic, metabolic, and neurologic dysfunctions when compared with patients fed with the control diet. There was no difference regarding the development of new gastrointestinal, hepatic, and respiratory dysfunction (Table 7) .
DISCUSSION
This study confirmed previously published results demonstrating the beneficial effects of an enteral diet enriched with EPA, GLA, and elevated level of antioxidant vitamins in patients with ARDS (3). The use of this diet in ARDS patients with severe sepsis and septic shock is associated with an improvement in oxygenation status, reduced mechanical ventilation time, fewer days in ICU, less new organ dysfunction, and a 19.4% absolute risk reduction in mortality rate. The diet used was an isonitrogenous and isocaloric enteral formula, differing from the control diet only in its lipid composition and level of antioxidant vitamins. Since there is evidence in the literature pointing toward the anti-inflammatory roles not only of EPA and GLA (38) but also of antioxidant vitamins alone (39 -41), the differences between both groups may be explained not just by the effects of EPA, GLA, or antioxidants but also by a combination of them. Kaplan-Meier estimate of survival curves during the 28-day period. The enteral feeding with eicosapentaenoic acid (EPA) and ␥-linolenic acid (GLA) (n ϭ 55) was associated with a significantly higher percentage of survival when compared with the control group (n ϭ 48) (p ϭ .037 using the log-rank test). Several studies in animal models of sepsis using these nutritional elements have succeeded in showing significant reductions in mortality (20 -23) . A previous work with ARDS patients had already indicated such a tendency. Gadek et al. (3) pointed to a difference in mortality rate of 19% for the control group vs. 12% for the group of patients fed with EPA ϩ GLA ϩ antioxidants, although this difference was not statistically significant (p ϭ .31).
Although both trials were designed to investigate the effect of this diet in patients with ARDS, certain differences prove to be particularly relevant. This study examines the effects of such a diet in a population of ARDS patients constituted solely by patients with severe sepsis or septic shock. Moreover, the present study enrolled patients with a PaO 2 /FIO 2 ratio Ͻ200 rather than Ͻ250. The heightened gravity of the patients used in the present study may have contributed to the greater number of days requiring mechanical ventilation and lower days outside ICU, when compared with previously published results (3).
This study allows only 6 hrs from the moment at which patients fulfilled all entry requirements to effective onset of diet, rather than 24 hrs, leading to a significant reduction in time necessary to achieve 75% of BEE ϫ 1.3. Recent studies have shown that time dependence is a determinant aspect in the treatment of septic patients.
For instance, the PROWESS study (4) showed a significant reduction in the mortality of severe septic patients with a high Acute Physiology and Chronic Health Evaluation II score and who were treated with recombinant human activated protein C in the first 48 hrs after fulfillment of study entry criteria. Nevertheless, the ENHANCE study showed that septic patients who were treated with recombinant human activated protein C in the first 24 hrs after meeting inclusion criteria had lower mortality rate than those patients who were treated after 24 hrs but within the first 48 hrs. The early use was also associated with a lower consumption of hospital resources including mechanical ventilation and the use of vasopressors (42) . Time-dependency was also associated with several other recommendations for the management of septic patients (24) .
Regarding oxygenation status, a significantly larger number of patients fed with the EPA ϩ GLA ϩ antioxidantenhanced diet were able to be extubated before day 7 when compared with those fed with the control diet (12 vs. two patients). This is due to the significant improvement in oxygenation status of patients receiving the study diet. Such improvement was already observed by day 4 and remained till day 7, different from patients who received the control diet in whom no significant improvement in oxygenation status was found. It is relevant to notice that the improvement took place in parallel with a decrease in FIO 2 and pos- itive end-expiratory pressure in addition to a progressive improvement in PaO 2 .
The respiratory tract is the most common site of infection in septic patients (4, 43) . Studies have demonstrated that Ͼ70% of critical septic patients require mechanical ventilation (27) , suggesting that the pulmonary inflammatory process has a fundamental role in regulating the systemic inflammatory response, which may lead the patient to a septic state or sustain this state of inflammatory hyperactivity. Patients fed with EPA ϩ GLA ϩ antioxidants during inflammatory diseases, such as ARDS, show significant reduction in recruitment of pulmonary neutrophils and lower level of proinflammatory mediators (16) . This is an important aspect since the mass inflammatory response is the most common path in ARDS and sepsis pathogenesis. An EPA ϩ GLA ϩ antioxidant-enriched diet may assist in restoring the balance between proand anti-inflammatory mediators by modulating the metabolism of arachidonic acid and also through synthesis of anti-inflammatory eicosanoids (16) .
Furthermore, the decrease in both mechanical ventilation days and period in intensive care, among the population of patients who used the study diet, indicates lower use of available resources. An important characteristic of this approach relates to the price of such an intervention, relatively low compared with other forms of treatment of the septic patient, although a pharmacoeconomic study is advised to evaluate this approach more consistently. In addition, this therapeutic intervention may be considered very safe.
Another important aspect is the number of patients who developed new organ failures not observed at baseline, considerably lower in the group that received the study diet. This reduction demonstrates a trend toward lower evolution of multiple organ dysfunction in patients fed with EPA ϩ GLA ϩ antioxidants. If we consider that the development of multiple organ dysfunctions is associated with increasing mortality rates, we can hypothesize this may be a determining factor in reducing the mortality rate.
It is important to consider that this work states the benefits of a diet enriched with EPA ϩ GLA ϩ antioxidants only in ARDS patients diagnosed with severe sepsis or septic shock and also that this therapy is useful only for those patients who are still able to receive enteral nutrition, despite their septic condition.
If we understand that patients with sepsis are under a persistent and uncontrolled state of inflammation, wherein the inflammatory reaction is capable of spreading indefinitely, leading the patient to severe shock, multiple organ failure, and death (44) , strategies for treatment capable of modulating this chain of inflammatory events may be considered for further investigation. We still need clinical trials evaluating the possible role of this diet in patients diagnosed with sepsis despite mechanical ventilation requirements.
CONCLUSIONS
This study showed the clinical efficacy of a low-carbohydrate, high-fat enteral formula containing an oil blend of EPA and GLA with elevated antioxidants in a population of critically ill patients with severe sepsis or septic shock requiring mechanical ventilation and tolerating enteral nutrition, suggesting that this enteral formulation can contribute to better ICU and hospital outcomes and is also associated with significantly lower mortality rates. The effects of this diet in the overall population of septic patients need further investigation.
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